⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1132116 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL27517423 | 0.97 | — | — | |
| Acetic Acid SCHEMBL15822518 | 0.86 | GABRR1 (0.39) | — | |
| SCHEMBL14346149 | 0.80 | — | — | |
| SCHEMBL18711223 | 0.79 | — | — | |
| SCHEMBL7876080 | 0.79 | — | — | |
| SCHEMBL113473 | 0.79 | — | — | |
| Acrylic Acid SCHEMBL28878466 | 0.78 | LMNA (0.43) | — | |
| SCHEMBL8530550 | 0.78 | ALDH1A1 (0.35) | — | |
| SCHEMBL8531439 | 0.78 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504883-B1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4504883-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | The Procter & Gamble Company (US) | 2025-02-12 | — | — | EP | disclosed |
| WO-2023196452-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-12 | — | — | WO | disclosed |
| US-20230323250-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | THE PROCTER & GAMBLE COMPANY | 2023-10-12 | — | — | US | disclosed |
| EP-1549651-B1 | PYRIMIDOPYRIMIDONES AS KINASE INHIBITORS | WARNER LAMBERT CO (US) | 2009-12-23 | — | — | EP | disclosed |
| US-7196090-B2 | Kinase inhibitors | WARNER-LAMBERT COMPANY (US) | 2007-03-27 | — | — | US | disclosed |
| WO-2006038112-A1 | USE OF KINASE INHIBITORS TO PROMOTE NEOCHONDROGENESIS | WARNER-LAMBERT COMPANY LLC (US) | 2006-04-13 | — | — | WO | disclosed |
| EP-1549651-A1 | KINASE INHIBITORS | Warner-Lambert Company LLC (US) | 2005-07-06 | — | — | EP | disclosed |
| WO-2004011465-A1 | KINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2004-02-05 | — | — | WO | disclosed |
| US-20040019210-A1 | Kinase inhibitors | CHIVIKAS CONNOLLY CLEO J (US) | 2004-01-29 | — | — | US | disclosed |